Test Code LAB518 Androstenedione, Serum
Performing Laboratory
Mayo Clinic Laboratories in RochesterReporting Name
Androstenedione, SSpecimen Type
Serum RedOrdering Guidance
Additional Testing Requirements
For diagnosis and differential diagnosis of hyperandrogenism, an initial workup in adults should also include total and bioavailable testosterone (TTBS / Testosterone, Total and Bioavailable, Serum) measurements. Depending on results, this may be supplemented with measurements of sex hormone-binding globulin (SHBG1 / Sex Hormone-Binding Globulin, Serum) and other androgenic steroids (eg, dehydroepiandrosterone sulfate [DHEA-S]).
For diagnosis of congenital adrenal hyperplasia (CAH), the following assays should also be ordered:
-OHPG / 17-Hydroxyprogesterone, Serum
-DHES1 / Dehydroepiandrosterone Sulfate, Serum
-CORT / Cortisol, Serum
For monitoring CAH treatment, the following assays should also be ordered:
-TTST / Testosterone, Total, Mass Spectrometry, Serum
-OHPG / 17-Hydroxyprogesterone, Serum
-DHES1 / Dehydroepiandrosterone Sulfate, Serum
-DHEA_ / Dehydroepiandrosterone [DHEA], Serum.
For diagnosis of premature adrenarche, the following assays should also be ordered:
-FSH / Follicle-Stimulating Hormone [FSH], Serum
-LH / Luteinizing Hormone [LH], Serum
-TTBS / Testosterone, Total and Bioavailable, Serum or TGRP / Testosterone, Total and Free, Serum
-EEST / Estradiol, Serum
-DHES1 / Dehydroepiandrosterone Sulfate, Serum
-DHEA_ / Dehydroepiandrosterone (DHEA), Serum
-SHBG1 / Sex Hormone-Binding Globulin, Serum
-OHPG / 17-Hydroxyprogesterone, Serum
Specimen Required
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.6 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | OK |
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 7 days |
Specimen Minimum Volume
0.25 mL
Special Instructions
Day(s) Performed
Monday through Friday
Specimen Retention Time
14 daysReport Available
2 to 5 daysReference Values
PEDIATRICS*
Premature infants
26-28 weeks, day 4: 92-282 ng/dL
31-35 weeks, day 4: 80-446 ng/dL
Full-term infants
1-7 days: 20-290 ng/dL
1 month-1 year: <69 ng/dL
Males*
Tanner stages |
Age (Years) |
Reference range (ng/dL) |
Stage I (prepubertal) |
<9.8 |
<51 |
Stage II |
9.8-14.5 |
31-65 |
Stage III |
10.7-15.4 |
50-100 |
Stage IV |
11.8-16.2 |
48-140 |
Stage V |
12.8-17.3 |
65-210 |
Females*
Tanner stages |
Age (Years) |
Reference range (ng/dL) |
Stage I (prepubertal) |
<9.2 |
<51 |
Stage II |
9.2-13.7 |
42-100 |
Stage III |
10.0-14.4 |
80-190 |
Stage IV |
10.7-15.6 |
77-225 |
Stage V |
11.8-18.6 |
80-240 |
*Soldin SJ, Brugnara C, Wong EC, eds. Androstenedione. In: Pediatric Reference Ranges. 4th ed. AACC Press; 2003: 32-34
ADULTS
Males: 40-150 ng/dL
Females: 30-200 ng/dL
For SI unit Reference Values, see www.mayocliniclabs.com/order-tests/si-unit-conversion.html
Useful For
Diagnosis and differential diagnosis of hyperandrogenism, in conjunction with measurements of other sex steroids
Diagnosis of congenital adrenal hyperplasia (CAH), in conjunction with measurement of other androgenic precursors, particularly, 17-alpha-hydroxyprogesterone (OHPG), 17 alpha-hydroxypregnenolone, dehydroepiandrosterone sulfate (DHEA-S), and cortisol
Monitoring CAH treatment, in conjunction with testosterone, OHPG, DHEA-S, and DHEA
Diagnosis of premature adrenarche, in conjunction with measurement of follicle-stimulating hormone and luteinizing hormone as well as other adrenal and gonadal sex-steroids and their precursors
Testing Algorithm
For more information see Steroid Pathways.
CPT Code Information
82157
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ANST | Androstenedione, S | 1854-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
7730 | Androstenedione, S | 1854-9 |
Supportive Data
To establish pediatric reference ranges, we compared adult levels obtained with our liquid chromatography tandem mass spectrometry methodology with adult levels obtained in other labs with their respective methodologies. We found excellent correlation (R=0.92, regression-trendline slope 1.07) with an extracted radioimmunoassay (RIA) method with preanalytical Sephradex column chromatography. This is the method used in Pediatric Reference Ranges, 4th edition and is based on reference 1. The ranges were further verified by comparison with another pediatric reference range publication, which used the same extracted RIA method with Sephradex column chromatography.(2)